tiprankstipranks
Trending News
More News >
Calumet Specialty Products (CLMT)
NASDAQ:CLMT
US Market

Calumet Specialty Products (CLMT) AI Stock Analysis

Compare
371 Followers

Top Page

CL

Calumet Specialty Products

(NASDAQ:CLMT)

49Neutral
Calumet Specialty Products faces significant financial challenges, particularly with profitability and leverage, which heavily impact its overall score. While technical analysis suggests some short-term momentum, the valuation remains unattractive due to unprofitability. Positive strides in strategic operations and debt reduction provide a more optimistic outlook, but underlying financial issues and market challenges continue to weigh down the score.
Positive Factors
Debt Management
Cash flow benefits from roughly $80M in annual debt service cost savings.
Leverage Reduction
The asset sale of the industrial portion of its Royal Purple® business for $110M will help with lowering leverage.
Sustainable Aviation Fuel (SAF)
The company is seen as having an opportunity to benefit from sustainable aviation fuel demand, making the current stock price attractive for investors.
Negative Factors
Interest Expenses
EBITDA will fall short of covering interest expenses in 1H 2025 as was the case for 2H.
Production Costs
Calumet Specialty Products has higher production costs for renewable diesel and sustainable aviation fuel compared to its competitors.
Regulatory Uncertainty
Regulatory uncertainty is a primary concern affecting the company's outlook.

Calumet Specialty Products (CLMT) vs. S&P 500 (SPY)

Calumet Specialty Products Business Overview & Revenue Model

Company DescriptionCalumet, Inc. manufactures, formulates, and markets slate of specialty branded products to various consumer-facing and industrial markets in North America and internationally. Its Specialty Products and Solutions segment offers various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. The company's Montana/Renewables segment focuses on processing renewable feedstocks into renewable hydrogen, renewable natural gas, renewable propane, renewable naphtha, renewable kerosene/aviation fuel, and renewable diesel. This segment also processes Canadian crude oil into conventional gasoline, diesel, jet fuel, and specialty grades of asphalt. Its Performance Brands segment blends, packages, and markets high performance products through Royal Purple, Bel-Ray, and TruFuel brands. Calumet GP, LLC serves as the general partner for Calumet Specialty Products Partners, L.P. The company was founded in 1916 and is headquartered in Indianapolis, Indiana.
How the Company Makes MoneyCalumet Specialty Products generates revenue primarily from the sale of its specialty hydrocarbon products. The company's key revenue streams include the production and distribution of finished lubricants, solvents, and waxes, which are sold to a broad customer base comprising industrial, automotive, and consumer markets. Calumet's revenue model is supported by its extensive manufacturing capabilities and refining expertise, allowing it to produce customized solutions tailored to specific customer needs. In addition, strategic partnerships and long-term supply agreements with key customers and suppliers play a significant role in ensuring stable demand and supply chain efficiency, contributing positively to the company's earnings.

Calumet Specialty Products Financial Statement Overview

Summary
Calumet Specialty Products is facing significant financial challenges across all aspects of its financial statements. The company is struggling with declining revenues, profitability issues, high leverage, negative equity, and deteriorating cash flow. These issues suggest a need for operational and financial restructuring to stabilize the business.
Income Statement
40
Negative
The company has experienced inconsistent revenue trends, with a decline from 2022 to 2023 and a slight increase in 2024. The gross profit margin has significantly reduced over the years, and net profit margin is negative, indicating profitability issues. EBIT and EBITDA margins have also decreased sharply, and the company reported a net loss in 2024, highlighting ongoing profitability challenges.
Balance Sheet
30
Negative
Calumet Specialty Products displays a high debt-to-equity ratio due to negative stockholders' equity, indicating financial instability and leverage risk. The equity ratio is concerning as liabilities exceed assets, and the return on equity (ROE) is not meaningful due to negative equity. These factors suggest potential solvency issues.
Cash Flow
35
Negative
The company struggles with negative free cash flow, and free cash flow has shown volatility over the years. Operating cash flow is negative in 2024, reflecting operational challenges. The free cash flow to net income ratio is negative, indicating cash flow issues despite reported losses. These metrics highlight liquidity concerns.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
4.19B4.18B4.69B3.15B2.27B
Gross Profit
230.80M451.70M350.80M142.90M210.10M
EBIT
8.10M267.20M133.40M-81.90M-68.60M
EBITDA
164.50M418.20M127.40M15.60M98.00M
Net Income Common Stockholders
-222.00M48.10M-171.80M-260.10M-149.00M
Balance SheetCash, Cash Equivalents and Short-Term Investments
38.10M7.90M35.20M38.10M109.40M
Total Assets
2.76B2.75B2.74B2.13B1.81B
Total Debt
2.34B2.19B1.67B1.58B1.41B
Net Debt
2.30B1.99B1.63B1.55B1.30B
Total Liabilities
3.22B3.00B3.03B2.51B1.94B
Stockholders Equity
-711.90M-491.60M-287.70M-10.10M-12.30M
Cash FlowFree Cash Flow
-123.10M-286.70M-435.60M-126.90M18.80M
Operating Cash Flow
-46.40M-14.90M100.60M-44.00M62.80M
Investing Cash Flow
-76.70M-271.80M-536.00M-82.80M-46.30M
Financing Cash Flow
154.30M266.20M348.70M139.30M73.80M

Calumet Specialty Products Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price12.32
Price Trends
50DMA
11.43
Positive
100DMA
14.88
Negative
200DMA
16.79
Negative
Market Momentum
MACD
0.09
Negative
RSI
61.53
Neutral
STOCH
91.83
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CLMT, the sentiment is Neutral. The current price of 12.32 is above the 20-day moving average (MA) of 10.49, above the 50-day MA of 11.43, and below the 200-day MA of 16.79, indicating a neutral trend. The MACD of 0.09 indicates Negative momentum. The RSI at 61.53 is Neutral, neither overbought nor oversold. The STOCH value of 91.83 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CLMT.

Calumet Specialty Products Peers Comparison

Overall Rating
UnderperformOutperform
Sector (56)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
ININR
77
Outperform
$1.06B
SBSBR
66
Neutral
$939.93M12.07798.58%8.33%-11.35%-11.76%
VTVTS
64
Neutral
$827.49M27.524.24%9.97%4.15%3.91%
KOKOS
60
Neutral
$736.13M4.03-1.15%-11.11%-105.10%
56
Neutral
$7.06B3.68-4.87%5.83%0.28%-51.94%
49
Neutral
$968.43M31.18%0.67%-6298.08%
* Energy Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CLMT
Calumet Specialty Products
12.32
-2.89
-19.00%
KOS
Kosmos Energy
1.79
-4.22
-70.22%
SBR
Sabine Royalty
64.47
4.34
7.22%
VTS
Vitesse Energy, Inc.
21.43
-0.24
-1.11%
TXO
TXO Energy Partners LP
17.00
-1.40
-7.61%
INR
Infinity Natural Resources, Inc. Class A
17.37
-4.52
-20.65%

Calumet Specialty Products Earnings Call Summary

Earnings Call Date:May 09, 2025
(Q1-2025)
|
% Change Since: 3.79%|
Next Earnings Date:Aug 08, 2025
Earnings Call Sentiment Positive
Calumet demonstrated strong financial and operational performance with successful debt reduction, strong specialty products performance, and accelerated project timelines in the renewable segment. However, challenges in the renewable market caused by regulatory changes and operational difficulties during winter posed some headwinds.
Q1-2025 Updates
Positive Updates
Successful DOE Loan and Debt Reduction
Calumet closed and funded the first DOE loan under the Trump administration, reducing annual cash flow from debt service by approximately $80 million per year.
Strong Specialty Products Performance
Specialty Products segment generated $56.3 million in adjusted EBITDA, with one of the highest quarters on record for SPS volumes at approximately 23,000 barrels per day.
Accretive Sale of Royal Purple Industrial Business
The sale brought in roughly $100 million of cash proceeds at an attractive multiple, streamlining the Performance Brands segment.
Cost Reduction Achievements
Operating costs were reduced by over $22 million compared to the previous year, driven by innovations at Montana Renewables and improvements in the specialty business.
MaxSAF Project Acceleration
Expectations improved for the Montana Renewables MaxSAF project, achieving 150 million gallons of SAF capacity more cheaply and quickly, with capital costs reduced from $150-$250 million to $20-$30 million.
Performance Brands Growth
Performance Brands segment posted strong quarterly results of $15.8 million, reflecting volume growth and commercial improvements.
Negative Updates
Challenging Renewable Market Dynamics
Montana Renewables generated $2.4 million of adjusted EBITDA, with significant cash losses linked to PTC changes and a record low index margin quarter.
Impact of Regulatory Environment
Uncertainty in RVO guidance and regulatory changes around BTC and PTC affected earnings visibility and market conditions.
Winter Operational Challenges
Freezing conditions in Northwest Louisiana posed operational challenges, impacting the first quarter's results.
Company Guidance
In the first quarter of 2025, Calumet, Inc. provided guidance on several key metrics, emphasizing strategic financial maneuvers and operational efficiencies. The company reported a successful quarter characterized by a $150 million partial call of 2026 notes as part of its deleveraging strategy and completion of the accretive sale of the Royal Purple industrial business. Calumet also forecasted a significant milestone in its Montana Renewables MaxSAF project, expecting to reach 150 million gallons of SAF capacity more cheaply and quickly than initially planned. Operationally, the company highlighted a $22 million reduction in total system operating costs, driven by a $5 per barrel cost reduction, despite a $4 million increase in natural gas expenses. The specialty business saw an 8% increase in production volume, with operational costs improved by $1.50 per barrel. Additionally, Montana Renewables generated $2.4 million of adjusted EBITDA in the first quarter, showcasing resilience in a challenging market environment. The company also announced an ambitious plan to increase SAF production to 120-150 million gallons by early 2026 for $20-$30 million of capital, leveraging existing assets for this expansion.

Calumet Specialty Products Corporate Events

Executive/Board ChangesPrivate Placements and Financing
Calumet Specialty Products Announces Leadership Change
Neutral
Apr 4, 2025

On March 31, 2025, Calumet, Inc. announced the immediate termination of its Equity Distribution Agreement with BMO Capital Markets Corp., which had allowed the company to sell up to $65 million of its common stock through an ‘at-the-market’ equity offering program. The company did not incur any penalties from this termination and had not sold any shares through the program. Additionally, on April 1, 2025, Vincent Donargo resigned as the Chief Accounting Officer, effective April 15, 2025, with David Lunin set to take over the role while maintaining his current positions within the company.

Executive/Board ChangesShareholder Meetings
Calumet Announces Retirement of Key Board Members
Neutral
Mar 18, 2025

On March 17, 2025, James S. Carter and Daniel L. Sheets informed the Board of Directors of Calumet, Inc. of their decisions to retire and not seek re-election at the end of their terms, which conclude at the 2025 Annual Meeting of Stockholders. Their retirements are not due to any disagreements with the company’s operations, policies, or practices.

Private Placements and FinancingBusiness Operations and Strategy
Calumet Specialty Products Streamlines Finances with Loan Guarantee
Positive
Feb 24, 2025

On February 18, 2025, Montana Renewables, LLC, a subsidiary of Calumet, Inc., terminated several financing agreements following the funding of the first tranche of a $1.44 billion loan guarantee from the U.S. Department of Energy. The termination of these agreements allowed MRL to repurchase key assets and repay outstanding loans, thereby streamlining its financial structure and potentially enhancing its operational efficiency.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.